PDCD1LG2 and systemic lupus erythematosus: In this study, we assessed the expression of PD-1, PD-L1 and PD-L2 in lymphoma tissue from 215 patients with pre-existing RA, SLE or pSS, and in 74 DLBCL controls without rheumatic disease for comparison.